Plasma brain-derived neurotrophic factor (BDNF), cytokines and platelet-related proteins during insulin-induced hypoglycemia and recovery in type 2 diabetes
Year: 2026
Type: article
Abstract: Introduction People with type 2 diabetes (T2D) face a substantially elevated risk of depression, and recurrent hypoglycemia may amplify this risk through disruption of neurotrophic signaling. Brain-derived neurotrophic factor (BDNF), a key regulator of neuronal survival and mood, is frequently dysregulated in T2D. This study investigated how insulin-induced hypoglycemia alters plasma BDNF, whether the cytokines interleukin-13 (IL-13) and interleukin-17A (IL-17A) track these changes, and whether platelet-related proteins associate with BDNF and cytokine dynamics. Methods In this exploratory secondary analysis of a prospective case-control study, individuals with T2D and age-matched controls (25 per group) underwent an insulin-induced hypoglycemic clamp. Plasma BDNF, IL-13, IL-17A, platelet factor 4 (PF4), pro-platelet basic protein (PPBP), P-selectin (SELP) and von Willebrand factor (vWF) were measured by SOMAscan proteomics at baseline, the nadir and 30 min to 24 h after hypoglycemia and analyzed with linear mixed-effects models. Results BDNF was higher in T2D across the time course (24%; p=0.021). It rose transiently at the nadir in both groups and remained below baseline from 2 to 24 h in T2D (−19% to −22%; false discovery rate [FDR] q ≤ 0.035), although the group × time interaction was not significant (p=0.77). In T2D, IL-13 and IL-17A fell below baseline at 2 and 4 h (−8% to −16%; q ≤ 0.046), and the fall in IL-17A was greater than in controls (interaction p=0.013). BDNF was independently associated with IL-13 (p=0.001) but not with IL-17A (p=0.19). PF4 and PPBP, co-stored with BDNF in platelet alpha-granules, were higher in T2D and correlated strongly with BDNF at all time points in both groups, including 24 h (R²=0.56–0.93, all p<0.001; robust in sensitivity analyses); they also correlated with IL-13 and IL-17A in T2D up to 1–2 h after hypoglycemia. SELP was elevated in T2D, whereas vWF showed no consistent associations. The group difference in BDNF was no longer significant after adjustment for body mass index or hypoglycemic exposure. Discussion Plasma BDNF therefore co-varied closely with platelet alpha-granule proteins and IL-13 after hypoglycemia. Whether repeated hypoglycemia lowers BDNF and contributes to depression risk in T2D requires testing in studies with direct measures of platelet and central BDNF and of depressive symptoms.
Source: Frontiers in Endocrinology
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $3,801
OpenAlex ID: W7225915624
